NASDAQ: BMRA
Biomerica Inc Stock Ownership - Who owns Biomerica?

Insider buying vs selling

Have Biomerica Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Allen BarbieriExecutive Vice Chairman2024-12-13110,000$0.31
$34.10kBuy
Catherine CosteDirector2024-12-1385,000$0.31
$26.35kBuy
Jane EmersonDirector2024-12-1385,000$0.31
$26.35kBuy
Zackary S. IraniChief Executive Officer2024-12-13250,000$0.31
$77.50kBuy
Gary LuChief Financial Officer2024-12-13155,000$0.31
$48.05kBuy
David MoatazediDirector2024-12-1385,000$0.31
$26.35kBuy

1 of 1

BMRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRA insiders and whales buy or sell their stock.

BMRA Shareholders

What type of owners hold Biomerica Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janet Moore12.79%2,605,228$1.48MInsider
Zackary S. Irani6.24%1,270,560$724.22kInsider
Granahan Investment Management LLC3.23%658,767$375.50kInstitution
Janet Trust Dtd 8. Moore3.12%635,977$362.51kInsider
William Snider2.46%500,000$285.00kInsider
The Broadoak Fund2.46%500,000$285.00kInsider
Allen Barbieri0.92%188,337$107.35kInsider
Vanguard Group Inc0.83%169,010$96.34kInstitution
Jane Emerson0.77%156,000$88.92kInsider
Gary Lu0.76%155,000$88.35kInsider

1 of 3

BMRA vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRA6.91%31.83%Net Buying
AIMD0.32%99.68%Net BuyingNet Buying
DHAI2.07%40.75%Net Buying
NURO0.64%99.36%Net BuyingNet Buying
WOK0.83%0.00%

Biomerica Stock Ownership FAQ

Who owns Biomerica?

Biomerica (NASDAQ: BMRA) is owned by 6.91% institutional shareholders, 31.83% Biomerica insiders, and 61.27% retail investors. Janet Moore is the largest individual Biomerica shareholder, owning 2.61M shares representing 12.79% of the company. Janet Moore's Biomerica shares are currently valued at $1.09M.

If you're new to stock investing, here's how to buy Biomerica stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.